The way a medicine is processed in the body is known as pharmacokinetics. So, how is the medicine absorbed, how is it dispersed throughout the body, where is it disseminated, how is it metabolized, and how is it eliminated? It is primarily concerned with the medication and the human body. The intricate interactions between the drug, the human body, and then the pathogen that may be causing an infection in the patient are taken into account by pharmacodynamics. So, how does the antibiotic destroy the pathogen that may be causing the infection, and how can we dose the medicine to maximize that killing activity profile?”
Pharmacokinetics can be defined as "what the body does to the drug." The intensity of a drug's impact in relation to its concentration in a body fluid, usually at the site of action, is referred to as pharmacodynamics. It can be summarized as follows: "what the medicine does to the body."
Title : Microemulsion based in situ gel of erythromycin for ocular ailments
Dasharath Muljibhai Patel, Graduate School of Pharmacy, India
Title : Nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, present successes and future prospects
A C Matin, Stanford University, United States
Title : Thymoquinone-induced cellular and mitochondrial health in hepatocellular and cholangiocellular carcinoma
Consolato M Sergi, University of Ottawa, Canada
Title : Points to consider for the manufacturing of cell and gene therapies
Richard Denk, SKAN AG, Switzerland
Title : Pharmacological features of sparsentan, a novel dual endothelin and angiotensin receptor antagonist
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Development and validation of RP-HPLC method for the dissolution study of tofacitinib in pharmaceutical solid dosage form
Narapereddy Krishna Prasad, Reckitt Benckiser LLC, United States
Title : Does erector spinae plane block improve respiratory outcomes in adults with rib fractures?
Katie Aldred, University of Liverpool, United Kingdom
Title : Interdisciplinary perspective towards therapeutic potential in antenatal care
Anita, DMIHER, India
Title : Augmented anti-atopic dermatitis effect of crisaborole nanoemulgel in 2,4-Di-nitrochlorobenzene induced (DNCB) atopic dermatitis (AD) in Balb/c mice
Dipti Srivastava, Hygia institute of pharmaceutical education and research, India
Title : Formulation, characterization and evaluation: Micellar loaded complex of cuminum cyminum to treat causing disease of COVID 19 (Respiratory Infection)
Rudra Pratap Singh Rajput, Royal College of Pharmacy, India